UBS Group’s Rapport Therapeutics RAPP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.11M | Buy |
273,507
+208,760
| +322% | +$2.37M | ﹤0.01% | 3455 |
|
|
2025
Q1 | $649K | Buy |
64,747
+43,419
| +204% | +$435K | ﹤0.01% | 4499 |
|
|
2024
Q4 | $378K | Buy |
21,328
+15,771
| +284% | +$280K | ﹤0.01% | 4873 |
|
|
2024
Q3 | $114K | Buy |
5,557
+2,430
| +78% | +$49.8K | ﹤0.01% | 5073 |
|
|
2024
Q2 | $72.7K | Buy |
+3,127
| New | +$72.7K | ﹤0.01% | 5257 |
|